Donafenib Monotherapy for Previously Treated Metastatic Colorectal Cancer
Clinical trial NCT02489916 · COMPLETED
Trial details
- NCT number
- NCT02489916
- Sponsor
- Suzhou Zelgen Biopharmaceuticals Co.,Ltd
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-01
- Primary completion
- 2015-10-01
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.